Literature DB >> 30248640

Novel biotechnological approaches to produce biological compounds: challenges and opportunities for science communication.

Lei Pei1, Markus Schmidt2.   

Abstract

Novel biotechnological approaches such as Metabolic Engineering (ME) and New Plant Breeding Techniques (NPBTs) are currently being developed to produce biological compounds for food and non-food products. NPBTs span a range of methods for in vivo production in crops, some of which are classified as GMOs while others aren't. Deploying such techniques will not only provide new opportunities for industry, but also challenges with respect to the regulatory environment. Similarly, the process of communicating these new techniques and their products to stakeholders and consumers will not be without its own challenges. We argue that scientists should engage more with non-scientists, either directly or through collaborators. These engagements should not only be about the science, we suggest, but also explicitly deal with real world ramifications, such as economic, environmental and social issues.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2018        PMID: 30248640     DOI: 10.1016/j.copbio.2018.08.012

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  3 in total

1.  New Hope for a "Cursed" Crop? Understanding Stakeholder Attitudes to Plant Molecular Farming With Modified Tobacco in Europe.

Authors:  Jonathan Menary; Mario Amato; Andrés Cid Sanchez; Matthew Hobbs; Agata Pacho; Sebastian S Fuller
Journal:  Front Plant Sci       Date:  2020-06-12       Impact factor: 5.753

Review 2.  Metabolic engineering of microbial cell factories for production of nutraceuticals.

Authors:  Shuo-Fu Yuan; Hal S Alper
Journal:  Microb Cell Fact       Date:  2019-03-11       Impact factor: 5.328

3.  Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products.

Authors:  Jonathan Menary; Matthew Hobbs; Sara Mesquita de Albuquerque; Agata Pacho; Pascal M W Drake; Alison Prendiville; Julian K-C Ma; Sebastian S Fuller
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.